Supply of Ambrisentan Tablets to NHS Scotland

Supply of Ambrisentan Tablets to NHS Scotland

Supply of ambrisentan 5 mg and 10 mg tablets (in various pack sizes) to NHS Scotland.

United Kingdom-Edinburgh: Pharmaceutical products

2020/S 134-331332

Contract notice

Supplies

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses

Official name: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘NSS’)
Postal address: Gyle Square (NSS Head Office), 1 South Gyle Crescent
Town: Edinburgh
NUTS code: UKM SCOTLAND
Postal code: EH12 9EB
Country: United Kingdom
E-mail: cameron.wright@nhs.net
Telephone: +44 1698794410

I.2)Information about joint procurement

The contract is awarded by a central purchasing body

I.3)Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at: https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html

I.4)Type of the contracting authority

Body governed by public law

I.5)Main activity

Health

Section II: Object

II.1)Scope of the procurement

II.1.1)Title:

Ambrisentan Tablets

Reference number: NP35920b

II.1.2)Main CPV code

33600000 Pharmaceutical products

II.1.3)Type of contract

Supplies

II.1.4)Short description:

Supply of ambrisentan tablets to NHS Scotland.

II.1.5)Estimated total value

Value excluding VAT: 5 000 000.00 GBP

II.1.6)Information about lots

This contract is divided into lots: no
II.2)Description
II.2.1)Title:

II.2.2)Additional CPV code(s)

33600000 Pharmaceutical products

II.2.3)Place of performance

NUTS code: UKM SCOTLAND
Main site or place of performance:

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

II.2.4)Description of the procurement:

Supply of ambrisentan 5 mg and 10 mg tablets (in various pack sizes) to NHS Scotland.

Goods are forecast to be supplied to patients predominantly via the Homecare route with nominal exception (0.004 %). There is a requirement for framework participants to supply goods to the nominated homecare suppliers.

The authority intends to award this framework as a single supplier framework per line.

Full details of goods and volumes can be found within the ITT documents.

II.2.5)Award criteria

Criteria below
Quality criterion – Name: Supply chain / Weighting: 10
Price – Weighting: 90

II.2.6)Estimated value

Value excluding VAT: 5 000 000.00 GBP

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 30
This contract is subject to renewal: yes
Description of renewals:

This framework includes the option to extend for up to a total period of eighteen (18) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation

III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

List and brief description of conditions:

Economic operators may be excluded from this competition if they are in breach of any situation referred to in Regulation 58 of the Public Contracts (Scotland) Regulations 2015.

III.1.2)Economic and financial standing

III.1.3)Technical and professional ability

List and brief description of selection criteria:

(a) potential framework participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered goods at the date of submission of the tender.

(b) potential framework participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.

(c) all tendered Goods must comply with the MHRA best practice guidance on labelling and packaging and the National Patient Safety Agency (‘NPSA’) guidelines on packaging and labelling on pack design.

Minimum level(s) of standards possibly required:

(a) confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered goods at the date of submission of the tender should be included in the qualification envelope of the ITT under the technical and professional ability: quality control.

(b) confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the qualification envelope of the ITT under the quality assurance schemes.

(c) confirmation that samples for tendered goods will be supplied upon request to ensure compliance with the MHRA best practice guidance on labelling and packaging and the National Patient Safety Agency (‘NPSA’) guidelines on packaging and labelling on pack design. Confirmation of sample provision should be provided in the qualification envelope of the ITT under technical and professional ability: products.

III.1.5)Information about reserved contracts
III.2)Conditions related to the contract
III.2.2)Contract performance conditions:
III.2.3)Information about staff responsible for the performance of the contract

Section IV: Procedure

IV.1)Description

IV.1.1)Type of procedure

Open procedure

IV.1.3)Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement
Framework agreement with a single operator
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6)Information about electronic auction

IV.1.8)Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure

IV.2.2)Time limit for receipt of tenders or requests to participate

Date: 18/08/2020
Local time: 12:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates

IV.2.4)Languages in which tenders or requests to participate may be submitted:

English

IV.2.6)Minimum time frame during which the tenderer must maintain the tender

Duration in months: 3 (from the date stated for receipt of tender)

IV.2.7)Conditions for opening of tenders

Date: 18/08/2020
Local time: 12:00

Section VI: Complementary information

VI.1)Information about recurrence

This is a recurrent procurement: no

VI.2)Information about electronic workflows

Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used

VI.3)Additional information:

The estimated value referred to in Section II.1.5) and II.2.6) covers the thirty (30) month contract duration and the eighteen (18) month extension period of the framework agreement.

The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 35795. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343

The contracting authority does not intend to include a sub-contract clause as part of community benefits (as per Section 25 of the Procurement Reform (Scotland) Act 2014) in this contract for the following reason:

It is not envisaged that sub-contractors will be utilised in delivery of this framework agreement.

The contracting authority does not intend to include any community benefit requirements in this contract for the following reason:

No Community Benefits will be deliverable through the award of this framework agreement.

(SC Ref:625156)

VI.4)Procedures for review

VI.4.1)Review body

Official name: Sheriff Court House
Postal address: 27 Chambers Street
Town: Edinburgh
Postal code: EH1 1LB
Country: United Kingdom
E-mail: edinburgh@scotcourts.gov.uk
VI.4.2)Body responsible for mediation procedures

VI.4.3)Review procedure

Precise information on deadline(s) for review procedures:

Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:

An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.

VI.4.4)Service from which information about the review procedure may be obtained

VI.5)Date of dispatch of this notice:

10/07/2020